Correction: The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with inhibition of both B cell differentiation and the production of inflammatory cytokines.
[This corrects the article DOI: 10.1371/journal.pone.0245986.].
Main Authors: | Su-Jin Moon, Jooyeon Jhun, Jaeyoon Ryu, Ji Ye Kwon, Se-Young Kim, KyoungAh Jung, Mi-La Cho, Jun-Ki Min |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0256716 |
Similar Items
-
The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with inhibition of both B cell differentiation and the production of inflammatory cytokines.
by: Su-Jin Moon, et al.
Published: (2021-01-01) -
RIPK1 inhibition attenuates experimental autoimmune arthritis via suppression of osteoclastogenesis
by: Jooyeon Jhun, et al.
Published: (2019-03-01) -
Liposome/gold hybrid nanoparticle encoded with CoQ10 (LGNP-CoQ10) suppressed rheumatoid arthritis via STAT3/Th17 targeting.
by: Jooyeon Jhun, et al.
Published: (2020-01-01) -
Sulforaphane is a Nrf2-independent inhibitor of mitochondrial fission
by: Gary B. O'Mealey, et al.
Published: (2017-04-01) -
SARS-CoV-2 spike protein promotes inflammatory cytokine activation and aggravates rheumatoid arthritis
by: A Ram Lee, et al.
Published: (2023-03-01)